JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma: Our findings support our hypothesis that the newly identified JAK3-INSL3 fusion transcript contributes to constitutive JAK3 activation, and this could be an additional mechanism of constitutive JAK3 activation in MF/SS CTCL.